Merendree Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Merendree Pharma
Largest movements
- Tangible fixed assets -€31,022
down €31,022 (-20.5%), from €151,046 to €120,024
of which Other tangible fixed assets: -€24,401
- Cash +€15,329
up €15,329 (+10.5%), from €145,548 to €160,878
mainly Net result for the year (+€57,939) and Depreciation (+€51,552)
- Debts after one year -€37,696
down €37,696 (-59.3%), from €63,536 to €25,839
- Trade debts +€20,124
up €20,124 (+195.5%), from €10,294 to €30,418
- Tax, wage and social debts -€7,317
down €7,317 (-36.0%), from €20,329 to €13,011
of which Taxes: -€7,335
- Accrued charges and deferred income -€5,149
down €5,149 (-44.6%), from €11,551 to €6,402
- Reserves +€4,839
up €4,839 (+1.8%), from €270,133 to €274,973
- Gross operating margin +€9,385
up €9,385 (+7.4%), from €126,462 to €135,847
- Taxes +€2,087
up €2,087 (+10.2%), from €20,360 to €22,446
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €465,456 | €441,017 | -€24,439 | -5.3% |
| Fixed assets | 21/28 | €151,046 | €120,024 | -€31,022 | -20.5% |
| Tangible fixed assets | 22/27 | €151,046 | €120,024 | -€31,022 | -20.5% |
| Plant, machinery and equipment | 23 | €1,785 | €5,749 | +€3,964 | +222.1% |
| Furniture and vehicles | 24 | €36,505 | €25,920 | -€10,585 | -29.0% |
| Other tangible fixed assets | 26 | €112,756 | €88,355 | -€24,401 | -21.6% |
| Current assets | 29/58 | €314,410 | €320,993 | +€6,583 | +2.1% |
| Stocks and contracts in progress | 3 | €111,120 | €109,521 | -€1,598 | -1.4% |
| Stocks | 30/36 | €111,120 | €109,521 | -€1,598 | -1.4% |
| Amounts receivable within one year | 40/41 | €4,145 | €993 | -€3,152 | -76.0% |
| Trade receivables | 40 | €611 | €993 | +€382 | +62.6% |
| Other amounts receivable | 41 | €3,534 | - | -€3,534 | |
| Current investments | 50/53 | €2,500 | €2,500 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €145,548 | €160,878 | +€15,329 | +10.5% |
| Deferred charges and accrued income | 490/1 | €51,097 | €47,101 | -€3,996 | -7.8% |
| Total equity and liabilities | 10/49 | €465,456 | €441,017 | -€24,439 | -5.3% |
| Equity | 10/15 | €276,333 | €281,173 | +€4,839 | +1.8% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €270,133 | €274,973 | +€4,839 | +1.8% |
| Distributable reserves | 133 | €270,133 | €274,973 | +€4,839 | +1.8% |
| Amounts payable | 17/49 | €189,123 | €159,844 | -€29,279 | -15.5% |
| Amounts payable after more than one year | 17 | €63,536 | €25,839 | -€37,696 | -59.3% |
| Financial debts | 170/4 | €63,536 | €25,839 | -€37,696 | -59.3% |
| Amounts payable within one year | 42/48 | €114,036 | €127,603 | +€13,566 | +11.9% |
| Current portion of amounts payable after more than one year | 42 | €37,113 | €37,696 | +€583 | +1.6% |
| Trade debts | 44 | €10,294 | €30,418 | +€20,124 | +195.5% |
| Suppliers | 440/4 | €10,294 | €30,418 | +€20,124 | +195.5% |
| Taxes, remuneration and social security | 45 | €20,329 | €13,011 | -€7,317 | -36.0% |
| Taxes | 450/3 | €17,040 | €9,704 | -€7,335 | -43.0% |
| Remuneration and social security | 454/9 | €3,289 | €3,307 | +€18 | +0.5% |
| Other amounts payable | 47/48 | €46,301 | €46,477 | +€176 | +0.4% |
| Accrued charges and deferred income | 492/3 | €11,551 | €6,402 | -€5,149 | -44.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €51,528 | €51,552 | +€24 | 0.0% |
| Other operating charges | 640/8 | €57 | €369 | +€311 | +545.0% |
| Gross operating margin | 9900 | €126,462 | €135,847 | +€9,385 | +7.4% |
| Operating profit (loss) | 9901 | €74,876 | €83,926 | +€9,049 | +12.1% |
| Financial income | 75/76B | €2 | €32 | +€30 | +1478.9% |
| Recurring financial income | 75 | €2 | €32 | +€30 | +1478.9% |
| Financial charges | 65/66B | €3,496 | €3,572 | +€76 | +2.2% |
| Recurring financial charges | 65 | €3,496 | €3,572 | +€76 | +2.2% |
| Profit (loss) for the period before taxes | 9903 | €71,382 | €80,386 | +€9,003 | +12.6% |
| Income taxes | 67/77 | €20,360 | €22,446 | +€2,087 | +10.2% |
| Profit (loss) for the period | 9904 | €51,022 | €57,939 | +€6,917 | +13.6% |
| Profit (loss) for the period to be appropriated | 9905 | €51,022 | €57,939 | +€6,917 | +13.6% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.